Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years

Hormozgan University of Medical Sciences

Status: Completed

Conditions: Upper Respiratory Tract Infections

Treatments: Drug: Placebo; Drug: Echinacea

Study type: Interventional

Funder types: Other

Identifiers

NCT01396889

Echinacea in URIs

Details and patient eligibility

About

Acute upper respiratory tract infections are the most commmon infections in children and are associated with complications such as acute otitis media, sinusitis and pneumonia. Echinacea is widely used for treatment of upper respiratoty tract infections. The aim of this study is to evaluate its efficacy as prophilaxis in children 1-5 years old.

Enrollment: 100 patients

Sex: All

Ages: 1 to 5 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Childrens 1-5 years old

Exclusion criteria

• Wheezing in previous 3 months requiring bronchodilatator
• History of hyperactive reactive airway
• using steroid or Echinacea
• chronic pulmonary of cardiac disease
• Acute respiratory disease within one week before study
• Allergic rhinitis
• Allergy to Echinacea
• avoiding to participate in the study

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

100 participants in 2 patient groups, including a placebo group

Echinacea

Experimental group

Description:

0.5ml daily for children 1-2 years old and 2ml daily for children2-5 years old for 3 months

Treatment:

Drug: Echinacea

Placebo

Placebo Comparator group

Description:

Placebo

Treatment:

Drug: Placebo